Quarry LP Astria Therapeutics, Inc. Transaction History

Quarry LP

$456 Billion
Q3 2025

A detailed history of Quarry LP transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Quarry LP holds 1,717 shares of ATXS stock, worth $21,582. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,717

Holding current value

$21,582

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Nov 14, 2025	BUY	$5.43 - $7.6 $9,323 - $13,049	1,717 New	1,717 $12.5 Million
Q1 2024 May 15, 2024	BUY	$6.99 - $16.69 $13,980 - $33,380	2,000 New	2,000 $28.2 Million

Others Institutions Holding ATXS

# of Institutions

116

Shares Held

50.7M

Call Options Held

37.9K

Put Options Held

50.8K

Perceptive Advisors LLC New York, NY

6.49M
Shares

$81.5 Million
0.1% of portfolio
Vestal Point Capital, LP New York, NY

4.96M
Shares

$62.3 Million
1.63% of portfolio
Fcpm Iii Services B.V. Naarden, P7

4.11M
Shares

$51.6 Million
5.98% of portfolio
Fairmount Funds Management LLC Philadelphia, PA

3.55M
Shares

$44.7 Million
5.59% of portfolio
Black Rock Inc. New York, NY

3.52M
Shares

$44.2 Million
0.0% of portfolio

View Full List

About Astria Therapeutics, Inc.

Ticker ATXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,178,000
Market Cap $191M
Description
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...

More about ATXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.

Account